Zealand Pharma A (ZEAL) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access ZEAL Annual Income Statement →
This income statement overview for Zealand Pharma A spans from Sep 30 2020 to Dec 31 2021, showing how the company's revenues, expenses, and earnings have changed across reporting periods.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ZEAL/income-statements
https://api.csimarket.com/api/v1/companies/ZEAL/fundamentals
https://api.csimarket.com/api/v1/companies/ZEAL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2021)
Q4 2021
0 0 0 (Sep 30 2020)
Revenues
Sales of Products4.80
Total Revenue46.55
Costs & Expenses
Cost of Goods and Services Sold18.90
Gross Profit27.64
Research and Development Expense-93.62
Other Operating Expense / -Income391.68
Total operating costs including COS213.98
Operating income / -loss-167.43
Net Interest (-)Expense / Income0.00
Other loss / -income-4.05
Total costs & expenses209.93
Income & Taxes
Income / -loss before income taxes-163.39
Income after income taxes-161.99
Net income / -loss of other equity1.40
Income / -loss from continuing operations-161.99
Net income / -loss-161.99
Income / -loss to shareholder-161.99
EBIT-163.39
EBITD-163.39
EBITDA-163.39
Earnings Per Share
Basic EPS (excl. extra items)-23.75
Basic Net EPS-23.75
Basic shares outstanding (Mill. of Units)42.87
Diluted Net EPS-23.75
Diluted average shares (Mill. of Units)42.87
4 historic quarters locked

Sign in to unlock the full Zealand Pharma A income statement history.

About ZEAL Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI